Stroke Rehabilitation: A Systemized and Hierarchized Rehabilitation Program for the Brazilian Unified Health System
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to systemize and hierarchize a rehabilitation program for the Brazilian Unified Health System in patients with stroke above 18 years of age and of both sexes. The main question it aims to answer is:
- Do patients with ischemic first episode of stroke have central nervous systems consequences due to peripheral and central nervous system sensibilization?
- Can stroke patients benefit from a systemized and hierarchized rehabilitation program with desensibilization interventions combined with multidisciplinary and educational programs? We will randomize 60 patients, 30 in each study arm. Researchers will compare the intervention group with an active control whose treatment is the institutional conventional program to see if innovative desensibilization strategies yield superior results. Authors will also investigate the role of genetic polymorphism and ancestrality in the outcome measures. Participants will undertake an innovative or conventional rehabilitation program, according to the randomization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2024
CompletedFirst Posted
Study publicly available on registry
July 10, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
July 31, 2024
July 1, 2024
2.2 years
July 2, 2024
July 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Motor recovery
Motor recovery measured with Fugl-Meyer Assessment (FMA), ranging from 0 to 100 for upper and lower extremities combined. Higher scores mean better outcome.
Change from baseline to six weeks of intervention.
Secondary Outcomes (9)
Functional independence
Change from baseline to six weeks of intervention.
Muscle strength
Change from baseline to six weeks of intervention.
Upper extremity recovery
Change from baseline to six weeks of intervention.
Spasticity reduction
Change from baseline to six weeks of intervention.
Gait recovery
Change from baseline to six weeks of intervention.
- +4 more secondary outcomes
Other Outcomes (15)
Physical Activity
Baseline.
Postural control
Change from baseline to six weeks of intervention.
Nutritional status
Baseline.
- +12 more other outcomes
Study Arms (2)
Conventional rehabilitation program
ACTIVE COMPARATORConventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program
Innovative rehabilitation program
EXPERIMENTALConventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program combined with innovative medical therapies (laser therapy, radial extracorporeal shockwaves therapy, focused extracorporeal shockwaves therapy, segmentary desensibilization with lidocaine, functional electrical stimulation - FES).
Interventions
Conventional rehabilitation program associated with innovative therapies.
Conventional rehabilitation program
Eligibility Criteria
You may qualify if:
- Clinical and radiological (magnetic resonance or tomography) diagnosis of ischemic stroke;
- Single episode of stroke;
- Clinical stability according to medical assessment;
- Time since stroke onset no longer than 24 months;
- Capacity to understand the study procedures;
- Eligible to be admitted to hospitalization at the institute where the study will be conducted
- Agree to sign the Informed Consent Form (ICF).
You may not qualify if:
- Presence of psychiatric disorders;
- Presence of subarachnoid hemorrhage;
- Presence of intracerebral hemorrhage;
- Presence of neuromuscular disorders;
- Presence of other neurological diseases or brain neoplasm;
- Presence of cognitive disorders measured with Montreal Cognitive Assessment (MoCA), scores below 20 points;
- Presence of systemic arterial hypertension (systolic blood pressure ≥ 185mmHg or diastolic blood pressure ≥ 110 mmHg).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sao Paulolead
- Ministry of Health, Brazilcollaborator
Study Sites (1)
Instituto de Medicina Física e Reabilitação (IMREA-FMUSP)
São Paulo, 04101-300, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marta Imamura, Professor
Instituto de Medicina Física e Reabilitação - FMUSP
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Different collaborators will be care providers and outcomes assessors.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 2, 2024
First Posted
July 10, 2024
Study Start
October 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
July 31, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After publication under reasonable request.
- Access Criteria
- Reasonable request and participants prior consent.
Study data will be made available under reasonable request after publication. Data will include de-identified participant data and the data dictionary. Requests can be submitted to the corresponding author. Request will be analyzed and ethical and legal implications of data sharing will be considered. Data will be shared after consent of study participants Brazil is under Brazilian General Data Protection Law (LGPD, English translation) and all shared data will require participants prior consent.